Fintel reports that on February 10, 2025, Canaccord Genuity downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) ...

Fintel reports that on February 10, 2025, Wells Fargo downgraded their outlook for Pliant Therapeutics (NasdaqGS:PLRX) from ...

The winners of the Travel Photographer Of The Year contest are a gorgeous visual journey through our changing planet and its ...

Once upon a time, in the heart of Sacramento, California, there was a magical place where childhood dreams came to life. No, ...

JMP Securities reiterated their market outperform rating on shares of Blue Owl Capital (NYSE:OWL – Free Report) in a research ...

Blue Owl Capital Inc. (NYSE:OWL – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the twelve ...

NEW YORK, Feb. 6, 2025 /PRNewswire/ -- Blue Owl Capital Inc. (NYSE:OWL) ("Blue Owl") today reported its financial results for the fourth quarter ended December 31, 2024. Blue Owl issued its full ...

I’m upgrading Blue Owl Capital stock to a Buy rating due to its expanding permanent capital base, strong fee-related earnings growth, and commitment to increasing dividends. Recent earnings ...

Alternative investment firm Blue Owl Capital is not planning to follow in the footsteps of competitors who have been setting up marketplaces for private credit loans. Blue Owl has grown into one ...

In a report released on February 7, Glenn Schorr from Evercore ISI maintained a Buy rating on Blue Owl Capital (OWL – Research Report), with a price target of $26.00. The company’s shares ...